<DOC>
	<DOCNO>NCT00958321</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , positron emission tomography compute tomography , may help learn extent disease allow doctor plan 3-dimensional conformal radiation therapy . PURPOSE : This phase II trial study side effect positron emission tomography compute tomography see well work plan treatment patient undergo 3-dimensional conformal radiation therapy non-small cell lung cancer remove surgery . This clinical study , patient treat use PET-CT-GTV : - The pilot study investigate technological feasibility - The Phase II study 2-stage Phase II study</brief_summary>
	<brief_title>Positron Emission Tomography Computed Tomography Planning Treatment Patients Undergoing 3-Dimensional Conformal Radiation Therapy Non-Small Cell Lung Cancer That Can Be Removed Surgery . ICORG 06-35</brief_title>
	<detailed_description>Pilot Study- Primary Objectives : - Prospective evaluation technical feasibility integrate PET-CT fusion St Luke 's Hospital - Rate PET-CT Scan base treatment delivery Pilot Study- Secondary Objectives : -Comparison GTV , PTV OAR DVHs conventional 3-DCRT plan PET-CT base 3-DCRT plan . Phase II Study- Primary Objective : -The safety PET-CT scan base radiotherapy , regard loco-regional disease control . Phase II Study- Secondary Objectives : -Comparison GTV , PTV OAR DVHs conventional 3-DCRT plan PET-CT base 3-DCRT plan .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Histologically prove ( biopsy cytology ) NSCLC ( SCC , Adenocarcinoma , Large Cell ) TNM clinical nonoperable stage I/II nonresectable stage IIIa/b without pleural effusion Measurable disease No malignancy , except nonmelanomatous skin cancer , within 5 year prior participation study ; diseasefree interval prior carcinoma must continuous Patient suitable radical 3DCRT ECOGPerformance status â‰¤ 2 / KPS &gt; equal 60 Weight loss &lt; 10 % within 3 month prior diagnosis No prior radiotherapy thorax Patient suitable lungboard immobilisation No chemotherapy receive prior plan PETCT scan Age 18 Provision write informed consent Evidence significant clinical disorder laboratory find make undesirable patient participate trial felt research / medical team patient may able comply protocol . FEV1 &lt; 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>malignant pleural effusion</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IA non-small cell lung cancer</keyword>
	<keyword>stage IB non-small cell lung cancer</keyword>
	<keyword>stage IIA non-small cell lung cancer</keyword>
	<keyword>stage IIB non-small cell lung cancer</keyword>
</DOC>